Marshall Wace’s PetMed Express PETS Stock Holding History

Marshall Wace’s Portfolio PETS Stock Details PETS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-11,373	Closed	-$46.1K	–	2852
2024 Q2	$46.1K	Buy	+11,373	New	+$48.6K	﹤0.01%	2451
2022 Q1	–	Sell	-46,357	Closed	-$1.17M	–	3856
2021 Q4	$1.17M	Buy	+46,357	New	+$1.28M	﹤0.01%	2399
2021 Q1	–	Sell	-61,767	Closed	-$1.98M	–	2768
2020 Q4	$1.98M	Buy	+61,767	New	+$1.9M	0.01%	960
2020 Q2	–	Sell	-6,732	Closed	-$194K	–	1859
2020 Q1	$194K	Buy	+6,732	New	+$176K	﹤0.01%	1183
2019 Q2	–	Sell	-181,661	Closed	-$4.14M	–	1727
2019 Q1	$4.14M	Sell	181,661 -326,650	-64%	-$7.36M	0.04%	525
2018 Q4	$11.8M	Buy	+508,311	New	+$13.6M	0.12%	203
2014 Q3	–	Sell	-12,734	Closed	-$172K	–	997
2014 Q2	$172K	Buy	+12,734	New	+$168K	﹤0.01%	872

Other funds holding PETS

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

OCMI

Oaktop Capital Management II Chatham, New Jersey $2.35B AUM 214.39% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Metavasi Capital Larchmont, New York $287M AUM 97.9% 1-Year Est. Return

Marshall Wace's PETS Position: Q3 2024 in Review

Marshall Wace sold out of PetMed Express (PETS) in Q3 2024, closing a stake of 11,373 shares — an estimated $46.1K sold.

Marshall Wace first reported a position in PETS in Q2 2014 and held it in 7 quarters. The position peaked at $11.8M in Q4 2018. 93 funds tracked by Wall St. Rank hold PETS as of Q3 2024.

Marshall Wace reported no remaining PetMed Express position as of Q3 2024 after selling out during the quarter.
Marshall Wace sold 11,373 PetMed Express shares in Q3 2024, an estimated $46.1K.
Marshall Wace first reported a position in PetMed Express in Q2 2014 and held it in 7 quarters.
Marshall Wace's PetMed Express position peaked at $11.8M in Q4 2018.
93 funds tracked by Wall St. Rank held PetMed Express as of Q3 2024.

Based on Marshall Wace's 13F filing for Q3 2024, filed 14 Nov 2024.